{"issuance_frequency":"","notes_translated":{"fr":"Pour participer au Régime, une entreprise pharmaceutique doit signer une entente commerciale avec un des pays importateurs admissibles afin de se procurer une quantité donnée d'un produit admissible apparaissant à l'annexe 1. Une entreprise pharmaceutique doit également présenter une demande d'autorisation auprès du commissaire aux brevets du Canada. Une fois l'autorisation ou la licence obligatoire reçue, l'entreprise doit respecter d'autres conditions.  ","en":"To participate in the Regime, a pharmaceutical company must enter into a sales agreement with an eligible importing country for the purchase of a specified amount of an eligible product listed on Schedule 1. A pharmaceutical company must also  submit an application for authorization to Canada's Commissioner of Patents. Once the authorization or compulsory licence is issued, there are additional terms and conditions that the company must meet and maintain. "},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"c29bfdfc-80e3-47ee-bdae-1d53656aa175","metadata_created":"2020-09-17T18:50:41.861137","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-09-17T18:50:41.861142","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-09-17","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Régime canadien d'accès aux médicaments","exigences pour les entreprises","entente commerciale","licence obligatoire","pays importateurs admissibles","produit admissible","demande d'autorisation auprès du commissaire aux brevets du Canada"],"en":["Company requirements under Canada's Access to Medicines Regime","sales agreement","compulsory licence","eligible importing country","eligible product","application for authorization to Canada's Commissioner of Patents."]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Exigences pour les entreprises : Régime canadien d'accès aux médicaments","en":"Company requirements under Canada's Access to Medicines Regime"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"c29bfdfc-80e3-47ee-bdae-1d53656aa175","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f737af44-651e-4d85-9f76-a569a2ef40ec","related_relationship":"","name_translated":{"fr":"Exigences pour les entreprises : Régime canadien d'accès aux médicaments","en":"Company requirements under Canada's Access to Medicines Regime"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Company requirements under Canada's Access to Medicines Regime","language":["en"],"created":"2020-09-17T18:50:41.962310","url":"https://www.canada.ca/en/health-canada/services/canada-access-medicines-regime/companies/requirements.html","last_modified":null,"position":0,"revision_id":"43b1b37c-c35b-4a0f-8421-7e2c035c571f","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"c29bfdfc-80e3-47ee-bdae-1d53656aa175","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f2172e54-f840-4297-b47f-5fd1aa652502","related_relationship":"","name_translated":{"fr":"Exigences pour les entreprises : Régime canadien d'accès aux médicaments","en":"Company requirements under Canada's Access to Medicines Regime"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Company requirements under Canada's Access to Medicines Regime","language":["fr"],"created":"2020-09-17T18:50:41.962315","url":"https://www.canada.ca/fr/sante-canada/services/regime-canadien-acces-medicaments/entreprises/exigences.html","last_modified":null,"position":1,"revision_id":"43b1b37c-c35b-4a0f-8421-7e2c035c571f","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2017-03-29 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"c29bfdfc-80e3-47ee-bdae-1d53656aa175","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"To participate in the Regime, a pharmaceutical company must enter into a sales agreement with an eligible importing country for the purchase of a specified amount of an eligible product listed on Schedule 1. A pharmaceutical company must also  submit an application for authorization to Canada's Commissioner of Patents. Once the authorization or compulsory licence is issued, there are additional terms and conditions that the company must meet and maintain. ","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Company requirements under Canada's Access to Medicines Regime","revision_id":"43b1b37c-c35b-4a0f-8421-7e2c035c571f"}